N-Acetylcysteine Reduces the Exacerbation Rate in Patients with Moderate to Severe COPD

Publisher： Karger

E-ISSN： 1423-0356|66|6|495-500

ISSN： 0025-7931

Source： Respiration, Vol.66, Iss.6, 1999-11, pp. : 495-500

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Onset and Duration of Action of Formoterol and Tiotropium in Patients with Moderate to Severe COPD

By  

Respiration, Vol. 73, Iss. 4, 2006-07 ,pp. : 414-419

Karger

Access to resources Recommend Favorite

N-Acetylcysteine Improves Arterial Vascular Reactivity in Patients with Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 112, Iss. 3, 2009-05 ,pp. : c184-c189

Karger

Access to resources Recommend Favorite

N-Acetylcysteine for the Management of Anemia and Oxidative Stress in Hemodialysis Patients

By  

Nephron Clin Pract, Vol. 116, Iss. 3, 2010-07 ,pp. : c207-c216

Karger

Access to resources Recommend Favorite

N‐Acetylcysteine in the treatment of trichotillomania: remarkable results in two patients

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 30, Iss. 9, 2016-09 ,pp. : 1606-1608

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation

By  

Respiration, Vol. 91, Iss. 1, 2016-0 ,pp. : 9-17

Karger

Access to resources Recommend Favorite